Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Prof Jeffrey Sachs presented with honorary doctorate at Spring Graduation Ceremony
2015-10-01

Prof Jeffrey Sachs (centre) with Prof Philippe Burger,
Head of Department: Economics (left), and
Prof HJ Kroukamp, Dean of the Faculty of Economic and
Management Sciences (right).
Photo: Charl Devenish

“Quality education is the best accelerator for sustainable growth. Universities have a unique role to play in this regard,” Prof Jeffrey Sachs said during a lecture he presented at the University of the Free State (UFS) Faculty of Economic and Management Sciences. He gave an insightful overview of the new Sustainable Development Goals (SDGs) of the United Nations. The 17 SDGs replace the Millennium Development goals of the past 15 years. In a major achievement, 193 countries will sign the goals at the United Nations (UN) in New York on 25 September 2015.

Prof Sachs is the director of The Earth Institute, Quetelet professor of Sustainable Development, and professor of Health Policy and Management at Columbia University. He is also a special advisor to the UN Secretary-General Ban Ki-moon on the Millennium Development Goals, and director of the UN Sustainable Development Solutions Network. Another accolade now added to his résumé is an honorary doctorate in Economics conferred on him by the UFS at the Spring Graduation Ceremony on 17 September 2015 for outstanding achievements and contribution to academia.

“South Africa is not achieving sustainable development. It has the highest inequality in the world with high unemployment among the youth. Quality education is the best accelerator for growth,” Prof Sachs said. He used the high education investment in Korea as an example of that country’s growth. Prof Sachs added that the government cannot achieve the SDGs on its own. “It is important for the country and universities to take on the goals. Universities can apply pressure, influence and provide solutions.”

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept